Advances in intelligent mass spectrometry data processing technology for in vivo analysis of natural medicines

Simian CHEN , Binxin DAI , Dandan ZHANG , Yuexin YANG , Hairong ZHANG , Junyu ZHANG , Di LU , Caisheng WU

Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (10) : 900 -913.

PDF (3558KB)
Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (10) :900 -913. DOI: 10.1016/S1875-5364(24)60687-4
Original article
research-article

Advances in intelligent mass spectrometry data processing technology for in vivo analysis of natural medicines

Author information +
History +
PDF (3558KB)

Abstract

Natural medicines (NMs) are crucial for treating human diseases. Efficiently characterizing their bioactive components in vivo has been a key focus and challenge in NM research. High-performance liquid chromatography-high-resolution mass spectrometry (HPLC-HRMS) systems offer high sensitivity, resolution, and precision for conducting in vivo analysis of NMs. However, due to the complexity of NMs, conventional data acquisition, mining, and processing techniques often fail to meet the practical needs of in vivo NM analysis. Over the past two decades, intelligent spectral data-processing techniques based on various principles and algorithms have been developed and applied for in vivo NM analysis. Consequently, improvements have been achieved in the overall analytical performance by relying on these techniques without the need to change the instrument hardware. These improvements include enhanced instrument analysis sensitivity, expanded compound analysis coverage, intelligent identification, and characterization of nontargeted in vivo compounds, providing powerful technical means for studying the in vivo metabolism of NMs and screening for pharmacologically active components. This review summarizes the research progress on in vivo analysis strategies for NMs using intelligent MS data processing techniques reported over the past two decades. It discusses differences in compound structures, variations among biological samples, and the application of artificial intelligence (AI) neural network algorithms. Additionally, the review offers insights into the potential of in vivo tracking of NMs, including the screening of bioactive components and the identification of pharmacokinetic markers. The aim is to provide a reference for the integration and development of new technologies and strategies for future in vivo analysis of NMs.

Keywords

High-performance liquid chromatography-High-resolution mass spectrometry / Data-acquisition / Data-processing / Artificial Intelligence / Metabolomics

Cite this article

Download citation ▾
Simian CHEN, Binxin DAI, Dandan ZHANG, Yuexin YANG, Hairong ZHANG, Junyu ZHANG, Di LU, Caisheng WU. Advances in intelligent mass spectrometry data processing technology for in vivo analysis of natural medicines. Chinese Journal of Natural Medicines, 2024, 22(10): 900-913 DOI:10.1016/S1875-5364(24)60687-4

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zhu MS, Zhang HY, Humphreys WG. Drug metabolite profiling and identification by high-resolution mass spectrometry[J]. J Biol Chem, 2011, 286(29): 25419-25425.

[2]

Yu Y, Yao C, Guo DA. Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry[J]. Acta Pharm Sin B, 2021, 11(6): 1469-1492.

[3]

Bai X, Zhu CY, Chen JY, et al. Recent progress on mass spectrum based approaches for absorption, distribution, metabolism, and excretion characterization of traditional Chinese medicine[J]. Curr Drug Metab, 2022, 23(2): 99-112.

[4]

Wen B, Zhu MS. Applications of mass spectrometry in drug metabolism: 50 years of progress[J]. Drug Metab Rev, 2015, 47(1): 71-87.

[5]

Wu HF, Guo J, Chen SL, et al. Recent developments in qualitative and quantitative analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry[J]. J Pharm Biomed Anal, 2013, 72: 267-291.

[6]

Wang HP, Chen CY, Liu Y, et al. Metabolic profile of Yi-Xin-Shu capsule in rat by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry analysis.[J]. RSC Adv, 2015, 5(98): 80583-80590.

[7]

Zhao WJ, Shang ZP, Li QQ, et al. Rapid screening and identification of daidzein metabolites in rats based on UHPLC-LTQ-Orbitrap mass spectrometry coupled with data-mining technologies[J]. Molecules, 2018, 23(1): 151.

[8]

Zhu HD, Wu XD, Huo JY, et al. A five-dimensional data collection strategy for multicomponent discovery and characterization in traditional Chinese medicine: Gastrodia Rhizoma as a case study[J]. J Chromatogr A, 2021, 1653: 462405.

[9]

Zuo R, Wang HJ, Si N, et al. LC-FT-ICR-MS analysis of the prototypes and metabolites in rat plasma after administration of Huang-Lian-Jie-Du decoction[J]. Acta Pharm Sin B, 2014, 49(02): 237-243.

[10]

Qiao X, Wang Q, Wang S, et al. Compound to extract to formulation: a knowledge-transmitting approach for metabolites identification of Gegen-Qinlian decoction, a traditional Chinese medicine formula[J]. Sci Rep, 2016, 6(1): 39534.

[11]

Yao M, Ma L, Duchoslav E, et al. Rapid screening and characterization of drug metabolites using multiple ion monitoring dependent product ion scan and postacquisition data mining on a hybrid triple quadrupole-linear ion trap mass spectrometer[J]. Rapid Commun Mass Sp, 2009, 23(11): 1683-1693.

[12]

Huang ML, Cheng ZZ, Wang L, et al. A targeted strategy to identify untargeted metabolites from in vitro to in vivo: rapid and sensitive metabolites profiling of licorice in rats using ultra-high performance liquid chromatography coupled with triple quadrupole-linear ion trap mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2018, 1092: 40-50.

[13]

Ni S, Qian D, Duan JA, et al. UPLC-QTOF/MS-based screening and identification of the constituents and their metabolites in rat plasma and urine after oral administration of Glechoma longituba extract[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2010, 878(28): 2741-2750.

[14]

Shi T, Yao ZH, Qin ZF, et al. Identification of absorbed constituents and metabolites in rat plasma after oral administration of Shen-Song-Yang-Xin using ultra-performance liquid chromatography combined with quadrupole time-of-flight mass spectrometry[J]. Biomed Chromatogr, 2015, 29(9): 1440-1452.

[15]

Tao JH, Zhao M, Wang DG, et al. UPLC-Q-TOF/MS-based screening and identification of two major bioactive components and their metabolites in normal and CKD rat plasma, urine and feces after oral administration of Rehmannia glutinosa Libosch extract[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 1001: 98-106.

[16]

Hao HP, Cui N, Wang GJ, et al. Global detection and identification of nontarget components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy[J]. Anal Chem, 2008, 80(21): 8187-8194.

[17]

Jin Y, Wu CS, Zhang JL, et al. A new strategy for the discovery of epimedium metabolites using high-performance liquid chromatography with high resolution mass spectrometry[J]. Anal Chim Acta, 2013, 768: 111-117.

[18]

Zhou W, Shan JJ, Meng MX. A two-step ultra-high-performance liquid chromatography-quadrupole/time of flight mass spectrometry with mass defect filtering method for rapid identification of analogues from known components of different chemical structure types in Fructus Gardeniae-Fructus Forsythiae herb pair extract and in rat’s blood[J]. J Chromatogr A, 2018, 1563: 99-123.

[19]

Tian TT, Jin YR, Ma YH, et al. Identification of metabolites of oridonin in rats with a single run on UPLC-Triple-TOF-MS/MS system based on multiple mass defect filter data acquisition and multiple data processing techniques[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 1006: 80-92.

[20]

Liu MY, Zhao SH, Wang ZQ, et al. Identification of metabolites of deoxyschizandrin in rats by UPLC-Q-TOF-MS/MS based on multiple mass defect filter data acquisition and multiple data processing techniques[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2014, 949-950: 115-126.

[21]

Lai HQ, Ouyang Y, Tian GH, et al. Rapid characterization and identification of the chemical constituents and the metabolites of Du-zhi pill using UHPLC coupled with quadrupole time-of-flight mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2022, 1209: 123433.

[22]

Feng W, Dong QJ, Liu MY, et al. Screening and identification of multiple constituents and their metabolites of Zhi-zi-chi decoction in rat urine and bile by ultra-high-performance liquid chromatography quadrupole time-of-flight mass spectrometry[J]. Biomed Chromatogr, 2017, 31(10): 3978.

[23]

Zhang JY, Cai W, Zhou Y, et al. Profiling and identification of the metabolites of baicalin and study on their tissue distribution in rats by ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2015, 985: 91-102.

[24]

Xie C, Zhong DF, Yu K, et al. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS[J]. Bioanalysis, 2012, 4(8): 937-959.

[25]

Gao Y, Zhang RP, Bai JF, et al. Targeted data-independent acquisition and mining strategy for trace drug metabolite identification using liquid chromatography coupled with tandem mass spectrometry[J]. Anal Chem, 2015, 87(15): 7535-7539.

[26]

Wang RH, Yin YD, Zhu ZJ. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology[J]. Anal Bioanal Chem, 2019, 411(19): 4349-4357.

[27]

Zha HH, Cai YP, Yin YD, et al. SWATHtoMRM: development of high-coverage targeted metabolomics method using SWATH technology for biomarker discovery[J]. Anal Chem, 2018, 90(6): 4062-4070.

[28]

Guo J, Huan T. Evaluation of significant features discovered from different data acquisition modes in mass spectrometry-based untargeted metabolomics[J]. Anal Chim Acta, 2020, 1137: 37-46.

[29]

Chen JY, Ding R, Jin Y, et al. HRPIF data mining based on data-dependent/independent acquisition for Rhei Radix et Rhizoma metabolite screening in rats[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2022, 1190: 123095.

[30]

Zhu CY, Cai TT, JIN Y, et al. Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes[J]. Pharmacol Res, 2020, 159: 104935.

[31]

Guo JD, Shang Y, Yang XH, et al. An online stepwise background subtraction-based ultra-high pressure liquid chromatography quadrupole time of flight tandem mass spectrometry dynamic detection integrated with metabolic molecular network strategy for intelligent characterization of the absorbed chemical-fingerprint of QiangHuoShengShi decoction in vivo[J]. J Chromatogr A, 2022, 1675: 463172.

[32]

Zhang X, Liao M, Cheng XY, et al. Ultrahigh‐performance liquid chromatography coupled with triple quadrupole and time-of-flight mass spectrometry for the screening and identification of the main flavonoids and their metabolites in rats after oral administration of Cirsium japonicum DC. extract [J]. Rapid Commun Mass Sp, 2018, 32(16): 1451-1461.

[33]

Zhang HY, Yang YO. An algorithm for thorough background subtraction from high-resolution LC/MS data: application for detection of glutathione-trapped reactive metabolites[J]. J Mass Spectrom, 2008, 43(9): 1181-1190.

[34]

Zhang HY, Ma L, He K, et al. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine[J]. J Mass Spectrom, 2008, 43(9): 1191-200.

[35]

Zhu PJ, Ding W, Tong W, et al. A retention-time-shift-tolerant background subtraction and noise reduction algorithm (BgS-NoRA) for extraction of drug metabolites in liquid chromatography/mass spectrometry data from biological matrices[J]. Rapid Commun Mass Sp, 2009, 23(11): 1563-1572.

[36]

Shekar V, Shah A, Shadid M, et al. An accelerated background subtraction algorithm for processing high-resolution MS data and its application to metabolite identification[J]. Bioanalysis, 2016, 8(16): 1693-1707.

[37]

Wu CS, Zhang HY, Wang CH, et al. An integrated approach for studying exposure, metabolism, and disposition of multiple component herbal medicines using high-resolution mass spectrometry and multiple data processing tools[J]. Drug Metab Dispos, 2016, 44(6): 800-808.

[38]

Zhu CY, Jiang XJ, Tian JJ, et al. Integrated approach toward absorption, distribution, metabolism, and excretion of Xiaoke pills in zebrafish based on UPLC-HRMS and DESI-MS techniques[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2022, 1200: 123276.

[39]

Plumb RS, Stumpf CL, Granger JH, et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids[J]. Rapid Commun Mass Sp, 2003, 17 (23): 2632-2638.

[40]

Guo MX, Zhao BS, Liu HY, et al. A metabolomic strategy to screen the prototype components and metabolites of Shuang-Huang-Lian Injection in human serum by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry[J]. J Anal Methods Chem, 2014, 2014: 241505.

[41]

Minale G, Seasong T, Temkitthawon P, et al. Characterization of metabolites in plasma, urine and feces of healthy participants after taking brahmi essence for twelve weeks using LC-ESI-QTOF-MS metabolomic approach[J]. Molecules, 2021, 26(10): 2944.

[42]

Wan MQ, Liu XY, Gao H, et al. Systematic analysis of the metabolites of Angelicae Pubescentis Radix by UPLC-Q-TOF-MS combined with metabonomics approaches after oral administration to rats[J]. J Pharm Biomed Anal, 2020, 188: 113445.

[43]

Jiang XJ, Chen SM, Zhu MS, et al. Global xenobiotic profiling of rat plasma using untargeted metabolomics and background subtraction-based approaches: method evaluation and comparison[J]. Curr Drug Metab, 2023, 24(3): 200-210.

[44]

Zhang HR, Jiang XJ, Zhang DD, et al. An integrated approach for studying the metabolic profiling of herbal medicine in mice using high-resolution mass spectrometry and metabolomics data processing tools[J]. J Chromatogr A, 2024, 1713: 464505.

[45]

Seddiki K, Saudemont P, Precioso F, et al. Cumulative learning enables convolutional neural network representations for small mass spectrometry data classification[J]. Nat Commun, 2020, 11(1): 5595.

[46]

Luo Y, Liu Y, Wen Q, et al. Comprehensive chemical and metabolic profiling of anti-hyperglycemic active fraction from Clerodendranthi Spicati Herba[J]. J Sep Sci, 2021, 44(9): 1805-1814.

[47]

Zeng J, Li YP, Wang CL, et al. Combination of in silico prediction and convolutional neural network framework for targeted screening of metabolites from LC-HRMS fingerprints: a case study of "Pericarpium Citri Reticulatae-Fructus Aurantii"[J]. Talanta, 2024, 269: 125514.

[48]

Ouyang XJ, Li JQ, Zhong YQ, et al. Identifying the active ingredients of carbonized Typhae Pollen by spectrum-effect relationship combined with MBPLS, PLS, and SVM algorithms [J]. J Pharm Biomed Anal, 2023, 235: 115619.

[49]

Chagas-Paula DA, Oliveira TB, Zhang T, et al. Prediction of anti-inflammatory plants and discovery of their biomarkers by machine learning algorithms and metabolomic studies[J]. Planta Med, 2015, 81 (6): 450-458.

[50]

Luo MD, Yin YD, Zhou ZW, et al. A mass spectrum-oriented computational method for ion mobility-resolved untargeted metabolomics[J]. Nat Commun, 2023, 14(1): 1813.

Funding

National Natural Science Foundation of China(82222068)

National Natural Science Foundation of China(82141215)

National Natural Science Foundation of China(82173779)

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(ZYYCXTD-D-202206)

Science and Technology Project of Fujian Province(2022J02057)

Science and Technology Project of Fujian Province(2021J02058)

Science and Technology Project of Fujian Province(2021I0003)

S&T Program of Hebei Province(23372508D)

PDF (3558KB)

74

Accesses

0

Citation

Detail

Sections
Recommended

/